| HOME >> BIOLOGY >> TECHNOLOGY |
Current assets:
Cash and cash equivalents $25,416,794 $24,602,202
Prepaid and other current assets 33,359 5,210
Investment in marketable securities - 628,585
Total current assets 24,450,153 25,235,997
Investment in other venture 179,497 173,427
Patents, net 594,051 637,267
Total assets $26,223,701 $$26,046,691
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accrued expenses and other current
liabilities $70,033 $61,307
Total current liabilities 70,033 61,307
Commitments
Stockholders' equity:
Common stock 132,857 132,857
Additional paid-in capital 59,844,355 59,844,355
Accumulated deficit (33,523,469) (33,183,960)
Accumulated other comprehensive
(loss) income - (507,793)
Treasury stock (300,075) (300,075)
Total stockholders' equity 25,153,668 25,985,384
Total liabilities and stockholders'
equity $26,223,701 $26,046,691
CADUS CORPORATION
Condensed Consolidated Statements of Income
(Unaudited)
Three Months Ended
June 30,
2007 2006
License and maintenance fees
'/>"/>
| SOURCE Cadus Corporation Copyright©2007 PR Newswire. All rights reserved |